Reduced FEV(1) as Prognostic Factors in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors

BACKGROUND: The aim of study is to investigate the influence of pulmonary function on the prognosis in patients with advanced non-small cell lung cancer (NSCLC) receiving immune checkpoint inhibitors (ICI). PATIENTS AND METHODS: Data were collected retrospectively from 151 patients with stage IV NSC...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Yi-Luen, Shen, Chia-I, Chiang, Chi-Lu, Huang, Hsu-Ching, Chou, Kun-Ta, Chiu, Chao-Hua, Chen, Yuh-Min, Luo, Yung-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980716/
https://www.ncbi.nlm.nih.gov/pubmed/35391883
http://dx.doi.org/10.3389/fmed.2022.860733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980716/
https://www.ncbi.nlm.nih.gov/pubmed/35391883
http://dx.doi.org/10.3389/fmed.2022.860733

Ejemplares similares